{
  "trial_id": "NCT03451500",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Age",
      "label": "met",
      "evidence": "57 years old"
    },
    {
      "criterion": "Willingness to maintain AREDS vitamin supplements",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Signed Informed Consent",
      "label": "met",
      "evidence": "signed"
    }
  ],
  "exclusion": [
    {
      "criterion": "Previous or current use of L-DOPA containing medication",
      "label": "not_met",
      "evidence": "no mention"
    },
    {
      "criterion": "Concurrent use of monoamine oxidase (MAO) inhibitors",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "BCVA worse than 20/100 in the eye with better BCVA",
      "label": "not_met",
      "evidence": "BCVA not mentioned"
    },
    {
      "criterion": "Current, or history of, neovascular AMD in either eye",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Neurologic conditions which can impair vision",
      "label": "not_met",
      "evidence": "no mention"
    },
    {
      "criterion": "Parkinson's Disease",
      "label": "not_met",
      "evidence": "no mention"
    },
    {
      "criterion": "Significant orthostatic hypotension",
      "label": "unknown",
      "evidence": ""
    },
    {
      "criterion": "Estimated glomerular filtration rate (eGFR) <20 ml/min",
      "label": "not_met",
      "evidence": "eGFR not mentioned"
    }
  ],
  "notes": "Patient has Wegener's granulomatosis and is being treated with corticosteroid and cyclophosphamides. His Birmingham Vasculitis Activity Score (BVAS) is above 4.",
  "_meta": {
    "topic_id": "54",
    "trial_id": "NCT03451500",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}